CompletedNot Applicable

Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia

France15 participantsStarted 2024-08-01

Plain-language summary

This study will help determine whether the SeptiCyte LAB test can accurately differentiate between SIRS and actual infections in postoperative patients, potentially reducing unnecessary antibiotic use and improving patient outcomes in cases of acute mesenteric ischemia

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient aged over 18 years * Affiliated to health assurance system * Hospitalized in the ICU for confirmed mesenteric ischemia\* for less than 24 hours with an indication for laparotomy * Hospitalized in the ICU for confirmed mesenteric ischemia\* who underwent laparotomy for revascularization or digestive resection less than 24 hours ago * Intraoperative bacteriological samples and blood cultures performed within 24 hours of medical management Exclusion Criteria: * decline to participate * no consent available

What they're measuring

Presence or absence of bacterial coinfection during acute mesenteric ischemia

Timeframe: Day 0 (pre operative)

Trial details

NCT IDNCT06507423

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Acute Mesenteric Ischemia trials